Form 4: Metagenomi COO Sells Shares to Cover Tax Obligations on RSU Vesting

Metagenomi, Inc.'s President and Chief Operating Officer, Jian Irish, sold 6,390 shares of common stock at $1.75 per share on June 6, 2025, solely to satisfy tax withholding obligations related to restricted stock unit vesting.

Summary

• Jian Irish, President and Chief Operating Officer, and Director of Metagenomi, Inc. (MGX), reported a transaction on June 6, 2025.
• The transaction involved the sale of 6,390 shares of Metagenomi common stock.
• The shares were sold at a price of $1.75 per share.
• Following this transaction, Jian Irish beneficially owns 315,543 shares of common stock.
• The sale was non-volitional, executed automatically to cover tax withholding obligations arising from the vesting of restricted stock units granted on April 1, 2024.

Sentiment

Score: 5

Explanation: The transaction is neutral as it's a non-volitional sale for tax purposes, a common occurrence with RSU vesting, and does not reflect a change in management's confidence in the company.

Positives

• The sale was explicitly stated as non-volitional, indicating it was not a discretionary sale based on a negative outlook by the insider.
• It was for the purpose of satisfying tax withholding obligations, which is a common and routine event for RSU vesting and does not imply a lack of confidence in the company.

Negatives

• A reduction in direct beneficial ownership by an insider, even if for tax purposes, technically decreases their direct stake in the company.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• "These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."

Industry Context

This Form 4 filing reports a routine insider transaction related to tax obligations upon RSU vesting, which is a common occurrence across all industries for executives receiving equity compensation. It does not provide specific insights into broader industry trends for the biotechnology or genomics sector.

Comparison to Industry Standards

• This transaction is a standard practice for executives receiving equity compensation, where a portion of vested shares are sold to cover tax liabilities.
• It aligns with typical compensation structures seen in publicly traded companies across various sectors, including biotech, and does not indicate any deviation from industry norms regarding insider trading practices for tax purposes.
• No specific comparable companies or projects are relevant for this type of routine insider filing.

Related Party Transactions

• Jian Irish, an officer and director of Metagenomi, Inc., sold 6,390 shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock units.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in direct insider ownership, but its non-volitional nature for tax purposes typically has minimal impact on investor sentiment or share price. It's a routine part of equity compensation for executives.

Next Steps

• The document does not mention any specific future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

Metagenomi, MGX, Form 4, Insider Transaction, Jian Irish, Restricted Stock Units, RSU Vesting, Tax Withholding, Beneficial Ownership